Chlamydia trachomatis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 58: Line 58:
:::* Alternative regimen (2):[[ Erythromycin]] base 500  mg PO qid for 7 days {{or}}  [[Erythromycin]]base 250 mg PO  qid for 14 days
:::* Alternative regimen (2):[[ Erythromycin]] base 500  mg PO qid for 7 days {{or}}  [[Erythromycin]]base 250 mg PO  qid for 14 days
:::* Alternative regimen (3):[[ Erythromycin]]  ethylsuccinate 800  mg PO qid for 7 days {{or}}  [[Erythromycin]] ethylsuccinate 400 mg PO four qid for 14days
:::* Alternative regimen (3):[[ Erythromycin]]  ethylsuccinate 800  mg PO qid for 7 days {{or}}  [[Erythromycin]] ethylsuccinate 400 mg PO four qid for 14days
Chlamydial Infections Among Neonates
::* Chlamydial infection amony neonates
::*
::* Pediatric
:::* Preferred regimen (1):[[ Erythromycin]] suspension,PO 50 mg/kg per day for 10 to 14 days
:::* Preferred regimen (2):[[ Clarithromycin]] suspension, 15 mg/kg per day for10 days
:::* Preferred regimen (3): [[Azithromycin ]]suspension, PO 10 mg/kg once on the first day, followed by 5 mg/kg qd daily for 4 days


::* Chlamydial infection among neonates
::*Ophthalmia Neonatorum
:::* Preferred regimen :[[ Erythromycin]]  base or ethylsuccinate ,PO 50 mg/kg/ day divided into 4 doses daily for 14 days
:::* Alternative regimen : [[Azithromycin ]]suspension, PO 20 mg/kg /day qd for 3 days


::*Infant Pneumonia
:::* Preferred regimen :[[ Erythromycin]]  base or ethylsuccinate PO 50 mg/kg/ day divided into 4 doses daily for 14 days
:::* Alternative regimen : [[Azithromycin ]]suspension, PO 20 mg/kg /day qd for 3 days





Revision as of 19:10, 24 June 2015


Chlamydia trachomatis
C. trachomatis inclusion bodies (brown) in a McCoy cell culture.
C. trachomatis inclusion bodies (brown) in a McCoy cell culture.
Scientific classification
Kingdom: Bacteria
Phylum: Chlamydiae
Order: Chlamydiales
Family: Chlamydiaceae
Genus: Chlamydia
Species: C. trachomatis
Binomial name
Chlamydia trachomatis
Busacca, 1935

Chlamydia trachomatis is one of three bacterial species in the genus Chlamydia, family Chlamydiaceae, class Chlamydiae, phylum Chlamydiae, domain Bacteria. C. trachomatis has only been found living inside the cells of humans, causing the following conditions:

In men

In women

In both sexes

C. trachomatis has also been detected in some patients with temporomandibular joint (TMJ) disease. It may be treated with any of several antibiotics: azithromycin, erythromycin or doxycycline/tetracycline.

C. trachomatis was the first chlamydial agent discovered in humans. It comprises two human biovars: trachoma and lymphogranuloma venereum (LGV). Many, but not all, C. trachomatis strains have an extrachromosomal plasmid. Chlamydia species are readily identified and distinguished from other chlamydial species using DNA-based tests. Most strains of C. trachomatis are recognized by monoclonal antibodies [mAbs] to epitopes in the VS4 region of MOMP. However, these mAbs may also crossreact with the other two Chlamydia species, Chlamydia suis and Chlamydia muridarum.

  • Chlamydial Infections in Adolescents and Adults
  • Pregancy
  • Chlamydial infection among neonates
  • Ophthalmia Neonatorum
  • Preferred regimen :Erythromycin base or ethylsuccinate ,PO 50 mg/kg/ day divided into 4 doses daily for 14 days
  • Alternative regimen : Azithromycin suspension, PO 20 mg/kg /day qd for 3 days
  • Infant Pneumonia
  • Preferred regimen :Erythromycin base or ethylsuccinate PO 50 mg/kg/ day divided into 4 doses daily for 14 days
  • Alternative regimen : Azithromycin suspension, PO 20 mg/kg /day qd for 3 days






Gallery

External links

ar:تراخوما da:Klamydia de:Chlamydia trachomatis nl:Chlamydia trachomatis no:Chlamydia trachomatis uk:Chlamydia trachomatis

Template:WikiDoc Sources

  1. Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 "Public Health Image Library (PHIL)".